EMA regular press briefing on COVID-19
The European Medicines Agency (EMA) holds fortnightly regular press briefings to provide an update on EMA’s COVID-19 activities. The next briefing will take place on Thursday, 9 December 2021.
- Marco Cavaleri (Head of Biological Health Threats and Vaccines Strategy)
- Fergus Sweeney (Head of Clinical Studies and Manufacturing Task Force)
- Georgy Genov (Head of Pharmacovigilance)
The press briefing will be moderated by Marie-Agnes Heine (Head of Communication).
The press briefing will be held in English. No translations will be provided.